Net profit of Aspira Pathlab & Diagnostics rose 740.00% to Rs 0.42 crore in the quarter ended June 2025 as against Rs 0.05 crore during the previous quarter ended June 2024. Sales rose 13.15% to Rs 5.25 crore in the quarter ended June 2025 as against Rs 4.64 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 5.25 | 4.64 | 13 |
OPM % | 12.95 | 5.60 | - |
PBDT | 0.79 | 0.42 | 88 |
PBT | 0.42 | 0.05 | 740 |
NP | 0.42 | 0.05 | 740 |